Het testen van de toevoeging van een antiangiogene geneesmiddel (bevacizumab) aan chemotherapie (carboplatine en paclitaxel) gecombineerd met immunotherapie (pembrolizumab) voor PMMR, TP53 gemuteerde endometriumkanker
Een gerandomiseerde fase II/III -studie van carboplatine, paclitaxel, pembrolizumab versus carboplatine, paclitaxel, cevacizumab versus carboplatine, paclitaxel, pembrolizumab, bevacizumab bij de behandeling van PMMR, TP53 Mutometrium kanker
This phase III trial compares the effect of bevacizumab in combination with carboplatin, paclitaxel and pembrolizumab to the usual treatments of carboplatin and paclitaxel with or without pembrolizumab in treating patients with stage III, IVA or IVB mismatch repair protein proficient (pMMR) and TP53 mutated endometrial cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has come back after a period of improvement (recurrent). Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Carboplatin is in a class of medications known as platinum-containing compounds. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Paclitaxel is in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Adding bevacizumab to the combination of carboplatin, paclitaxel and pembrolizumab may be more effective than the usual treatment combinations of carboplatin and paclitaxel with or without pembrolizumab in treating patients with advanced or recurrent pMMR and TP53 mutated endometrial cancer.
Studie Overzicht
Toestand
Gedetailleerde beschrijving
PRIMARY OBJECTIVE:
I. To demonstrate that bevacizumab, an anti-VEGF antibody therapy, (or an anti-VEGF antibody biosimilar) in combination with carboplatin, paclitaxel, and pembrolizumab is superior to carboplatin, paclitaxel, and pembrolizumab (the control arm) or carboplatin, paclitaxel, and bevacizumab in prolonging progression-free survival (PFS) in patients with pMMR, TP53 mutated advanced stage (III or IV) or recurrent endometrial cancer.
SECONDARY OBJECTIVES:
I. To demonstrate that bevacizumab in combination with carboplatin, paclitaxel, and pembrolizumab is superior to carboplatin, paclitaxel, and pembrolizumab or carboplatin, paclitaxel, and bevacizumab in prolonging overall survival (OS) in patients with pMMR, TP53 mutated advanced stage (III or IV) or recurrent endometrial cancer.
II. To examine the impact of the addition of bevacizumab in combination with carboplatin and paclitaxel or with carboplatin, paclitaxel, and pembrolizumab on PFS and OS based on type of p53 immunohistochemistry (IHC) aberrancy (over expression/cytoplasmic expression versus null [complete absence of staining]) and mutation type.
III. To evaluate toxicity on treatment with bevacizumab when combined with carboplatin, paclitaxel, and/or pembrolizumab as assessed by Common Terminology Criteria for Adverse Events (CTCAE) version (v.)5.0.
IV. To explore the anti-tumor activity in each treatment arm as assessed by objective response rate in the subset of patients with measurable disease by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM 1 (REFERENCE ARM): Patients receive paclitaxel intravenously (IV) over 3 hours, carboplatin IV and pembrolizumab IV over 30 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance pembrolizumab IV over 30 minutes on day 1 of each cycle. Cycles repeat every 6 weeks for up to an additional14 cycles. Additionally, patients undergo urine and blood sample collection and computed tomography (CT) or magnetic resonance imaging (MRI) throughout the study.
ARM 2 (EXPERIMENTAL TRIPLET ARM): Patients receive paclitaxel IV over 3 hours, carboplatin IV, and bevacizumab IV or anti-VEGF antibody biosimilar on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance bevacizumab IV on day 1 of each cycle. Treatment repeats every 3 weeks for up to an additional 28 doses. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study.
ARM 3 (EXPERIMENTAL QUADRUPLET ARM): Patients receive paclitaxel IV over 3 hours, carboplatin IV, pembrolizumab IV over 30 minutes, and bevacizumab IV or anti-VEGF antibody biosimilar on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance pembrolizumab IV over 30 minutes every 6 weeks for up to an additional 14 cycles and bevacizumab IV every 3 weeks for up to an additional 28 doses. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study.
After completion of study treatment, patients are followed every 3 months for 2 years then every 6 months for up to 3 years.
Studietype
Inschrijving (Geschat)
Fase
- Fase 3
Contacten en locaties
Studie Locaties
-
-
Alabama
-
Birmingham, Alabama, Verenigde Staten, 35233
- Werving
- University of Alabama at Birmingham Cancer Center
-
Hoofdonderzoeker:
- Michael D. Toboni
-
Contact:
- Site Public Contact
- E-mail: gingerreeves@uabmc.edu
-
-
Alaska
-
Anchorage, Alaska, Verenigde Staten, 99508
- Werving
- Alaska Women's Cancer Care
-
Hoofdonderzoeker:
- Dan S. Zuckerman
-
Contact:
- Site Public Contact
- Telefoonnummer: 907-212-6871
- E-mail: AKPAMC.OncologyResearchSupport@providence.org
-
-
Arizona
-
Phoenix, Arizona, Verenigde Staten, 85004
- Werving
- Cancer Center at Saint Joseph's
-
Hoofdonderzoeker:
- Loretta J. Nastoupil
-
Contact:
- Site Public Contact
- Telefoonnummer: 720-874-1881
- E-mail: ResearchInstituteInquiries@CommonSpirit.org
-
Tucson, Arizona, Verenigde Staten, 85719
- Werving
- Banner University Medical Center - Tucson
-
Contact:
- Site Public Contact
- E-mail: UACC-IIT@uacc.arizona.edu
-
Hoofdonderzoeker:
- Marina D. Miller
-
Tucson, Arizona, Verenigde Staten, 85719
- Werving
- University of Arizona Cancer Center-North Campus
-
Contact:
- Site Public Contact
- E-mail: UACC-IIT@uacc.arizona.edu
-
Hoofdonderzoeker:
- Marina D. Miller
-
-
Arkansas
-
Fayetteville, Arkansas, Verenigde Staten, 72703
- Werving
- Highlands Oncology Group - Fayetteville
-
Hoofdonderzoeker:
- Joseph T. Beck
-
Contact:
- Site Public Contact
- Telefoonnummer: 479-872-8100
- E-mail: research@hogonc.com
-
Little Rock, Arkansas, Verenigde Staten, 72205
- Werving
- University of Arkansas for Medical Sciences
-
Contact:
- Site Public Contact
- Telefoonnummer: 501-686-8274
-
Hoofdonderzoeker:
- Heather R. Williams
-
Rogers, Arkansas, Verenigde Staten, 72758
- Werving
- Highlands Oncology Group - Rogers
-
Hoofdonderzoeker:
- Joseph T. Beck
-
Contact:
- Site Public Contact
- Telefoonnummer: 479-872-8130
- E-mail: research@hogonc.com
-
Springdale, Arkansas, Verenigde Staten, 72762
- Werving
- Highlands Oncology Group
-
Hoofdonderzoeker:
- Joseph T. Beck
-
Contact:
- Site Public Contact
- Telefoonnummer: 479-872-8130
- E-mail: research@hogonc.com
-
-
California
-
Carmichael, California, Verenigde Staten, 95608
- Werving
- Mercy San Juan Medical Center
-
Hoofdonderzoeker:
- Loretta J. Nastoupil
-
Contact:
- Site Public Contact
- Telefoonnummer: 720-874-1881
- E-mail: ResearchInstituteInquiries@commonspirit.org
-
Carmichael, California, Verenigde Staten, 95608
- Werving
- Mercy Cancer Center - Carmichael
-
Hoofdonderzoeker:
- Loretta J. Nastoupil
-
Contact:
- Site Public Contact
- Telefoonnummer: 720-874-1881
- E-mail: ResearchInstituteInquiries@CommonSpirit.org
-
Dublin, California, Verenigde Staten, 94568
- Werving
- Kaiser Permanente Dublin
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
-
Elk Grove, California, Verenigde Staten, 95758
- Werving
- Mercy Cancer Center - Elk Grove
-
Hoofdonderzoeker:
- Loretta J. Nastoupil
-
Contact:
- Site Public Contact
- Telefoonnummer: 720-874-1881
- E-mail: ResearchInstituteInquiries@CommonSpirit.org
-
Fremont, California, Verenigde Staten, 94538
- Werving
- Kaiser Permanente-Fremont
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
Fresno, California, Verenigde Staten, 93720
- Werving
- Kaiser Permanente Fresno Orchard Plaza
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 833-574-2273
-
Los Angeles, California, Verenigde Staten, 90048
- Werving
- Cedars-Sinai Medical Center
-
Hoofdonderzoeker:
- Emily N. Prendergast
-
Contact:
- Site Public Contact
- Telefoonnummer: 310-423-2133
- E-mail: Cancer.trial.info@cshs.org
-
Los Angeles, California, Verenigde Staten, 90033
- Werving
- USC / Norris Comprehensive Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 323-865-0451
-
Hoofdonderzoeker:
- Koji Matsuo
-
Los Angeles, California, Verenigde Staten, 90033
- Werving
- Los Angeles General Medical Center
-
Hoofdonderzoeker:
- Koji Matsuo
-
Contact:
- Site Public Contact
- Telefoonnummer: 323-865-0451
- E-mail: uscnorrisinfo@med.usc.edu
-
Modesto, California, Verenigde Staten, 95356
- Werving
- Kaiser Permanente- Modesto MOB II
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
-
Oakland, California, Verenigde Staten, 94611
- Werving
- Kaiser Permanente-Oakland
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
Palo Alto, California, Verenigde Staten, 94304
- Werving
- Stanford Cancer Institute Palo Alto
-
Hoofdonderzoeker:
- Kristin L. Bixel
-
Contact:
- Site Public Contact
- Telefoonnummer: 650-498-7061
- E-mail: cancertrialsinfo@stanford.edu
-
Rancho Mirage, California, Verenigde Staten, 92270
- Werving
- Eisenhower Medical Center
-
Hoofdonderzoeker:
- Mark Genesen
-
Contact:
- Site Public Contact
- Telefoonnummer: 760-834-3798
-
Rocklin, California, Verenigde Staten, 95765
- Werving
- Mercy Cancer Center - Rocklin
-
Hoofdonderzoeker:
- Loretta J. Nastoupil
-
Contact:
- Site Public Contact
- Telefoonnummer: 720-874-1881
- E-mail: ResearchInstituteInquiries@CommonSpirit.org
-
Roseville, California, Verenigde Staten, 95661
- Werving
- Kaiser Permanente-Roseville
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
Sacramento, California, Verenigde Staten, 95817
- Werving
- University of California Davis Comprehensive Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 916-734-3089
-
Hoofdonderzoeker:
- Nancy T. Nguyen
-
Sacramento, California, Verenigde Staten, 95814
- Werving
- Kaiser Permanente Downtown Commons
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: kpoct@kp.org
-
Sacramento, California, Verenigde Staten, 95823
- Werving
- Kaiser Permanente-South Sacramento
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
Sacramento, California, Verenigde Staten, 95816
- Werving
- Mercy Cancer Center - Sacramento
-
Hoofdonderzoeker:
- Loretta J. Nastoupil
-
Contact:
- Site Public Contact
- Telefoonnummer: 720-874-1881
- E-mail: ResearchInstituteInquiries@CommonSpirit.org
-
San Francisco, California, Verenigde Staten, 94115
- Werving
- Kaiser Permanente-San Francisco
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
San Jose, California, Verenigde Staten, 95119
- Werving
- Kaiser Permanente-Santa Teresa-San Jose
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
San Leandro, California, Verenigde Staten, 94577
- Werving
- Kaiser Permanente San Leandro
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
San Rafael, California, Verenigde Staten, 94903
- Werving
- Kaiser San Rafael-Gallinas
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
Santa Clara, California, Verenigde Staten, 95051
- Werving
- Kaiser Permanente Medical Center - Santa Clara
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
Santa Rosa, California, Verenigde Staten, 95403
- Werving
- Kaiser Permanente-Santa Rosa
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
South San Francisco, California, Verenigde Staten, 94080
- Werving
- Kaiser Permanente-South San Francisco
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
Vallejo, California, Verenigde Staten, 94589
- Werving
- Kaiser Permanente-Vallejo
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
Walnut Creek, California, Verenigde Staten, 94596
- Werving
- Kaiser Permanente-Walnut Creek
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-642-4691
- E-mail: Kpoct@kp.org
-
Woodland, California, Verenigde Staten, 95695
- Werving
- Woodland Memorial Hospital
-
Hoofdonderzoeker:
- Loretta J. Nastoupil
-
Contact:
- Site Public Contact
- Telefoonnummer: 720-874-1881
- E-mail: ResearchInstituteInquiries@CommonSpirit.org
-
-
Colorado
-
Aurora, Colorado, Verenigde Staten, 80045
- Werving
- UCHealth University of Colorado Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 720-848-0650
-
Hoofdonderzoeker:
- Bradley R. Corr
-
Colorado Springs, Colorado, Verenigde Staten, 80909
- Werving
- UCHealth Memorial Hospital Central
-
Contact:
- Site Public Contact
- Telefoonnummer: 719-365-2406
-
Hoofdonderzoeker:
- Bradley R. Corr
-
Colorado Springs, Colorado, Verenigde Staten, 80920
- Werving
- Memorial Hospital North
-
Contact:
- Site Public Contact
- Telefoonnummer: 719-364-6700
-
Hoofdonderzoeker:
- Bradley R. Corr
-
Fort Collins, Colorado, Verenigde Staten, 80524
- Werving
- Poudre Valley Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 970-297-6150
-
Hoofdonderzoeker:
- Bradley R. Corr
-
Fort Collins, Colorado, Verenigde Staten, 80528
- Werving
- Cancer Care and Hematology-Fort Collins
-
Contact:
- Site Public Contact
- Telefoonnummer: 412-339-5294
- E-mail: Roster@nrgoncology.org
-
Hoofdonderzoeker:
- Bradley R. Corr
-
Greeley, Colorado, Verenigde Staten, 80631
- Werving
- UCHealth Greeley Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 412-339-5294
- E-mail: Roster@nrgoncology.org
-
Hoofdonderzoeker:
- Bradley R. Corr
-
Highlands Ranch, Colorado, Verenigde Staten, 80129
- Werving
- UCHealth Highlands Ranch Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 720-848-0650
-
Hoofdonderzoeker:
- Bradley R. Corr
-
Loveland, Colorado, Verenigde Staten, 80538
- Werving
- Medical Center of the Rockies
-
Contact:
- Site Public Contact
- Telefoonnummer: 970-203-7083
-
Hoofdonderzoeker:
- Bradley R. Corr
-
-
Connecticut
-
Hartford, Connecticut, Verenigde Staten, 06102
- Werving
- Hartford Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 860-545-5363
-
Hoofdonderzoeker:
- Amy K. Brown
-
Manchester, Connecticut, Verenigde Staten, 06042
- Werving
- Hartford HealthCare - Manchester
-
Contact:
- Site Public Contact
- Telefoonnummer: 860-972-4700
-
Hoofdonderzoeker:
- Amy K. Brown
-
New Britain, Connecticut, Verenigde Staten, 06050
- Werving
- The Hospital of Central Connecticut
-
Hoofdonderzoeker:
- Amy K. Brown
-
Contact:
- Site Public Contact
- Telefoonnummer: 860-224-5660
-
-
Delaware
-
Millville, Delaware, Verenigde Staten, 19967
- Werving
- Beebe South Coastal Health Campus
-
Contact:
- Site Public Contact
- Telefoonnummer: 302-291-6730
- E-mail: research@beebehealthcare.org
-
Hoofdonderzoeker:
- Gregory A. Masters
-
Newark, Delaware, Verenigde Staten, 19713
- Werving
- Helen F Graham Cancer Center
-
Hoofdonderzoeker:
- Gregory A. Masters
-
Contact:
- Site Public Contact
- Telefoonnummer: 302-623-4450
- E-mail: lbarone@christianacare.org
-
Newark, Delaware, Verenigde Staten, 19713
- Werving
- Medical Oncology Hematology Consultants PA
-
Hoofdonderzoeker:
- Gregory A. Masters
-
Contact:
- Site Public Contact
- Telefoonnummer: 302-623-4450
- E-mail: lbarone@christianacare.org
-
Rehoboth Beach, Delaware, Verenigde Staten, 19971
- Werving
- Beebe Health Campus
-
Contact:
- Site Public Contact
- Telefoonnummer: 302-291-6730
- E-mail: research@beebehealthcare.org
-
Hoofdonderzoeker:
- Gregory A. Masters
-
-
District of Columbia
-
Washington D.C., District of Columbia, Verenigde Staten, 20010
- Werving
- MedStar Washington Hospital Center
-
Hoofdonderzoeker:
- Ebony R. Hoskins
-
Contact:
- Site Public Contact
- Telefoonnummer: 202-877-8839
-
-
Florida
-
N. Venice, Florida, Verenigde Staten, 34275
- Werving
- Sarasota Memorial Hospital-Venice
-
Contact:
- Site Public Contact
- Telefoonnummer: 941-261-9000
-
Hoofdonderzoeker:
- Toni P. Kilts
-
Sarasota, Florida, Verenigde Staten, 34239
- Werving
- Sarasota Memorial Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 941-917-2225
-
Hoofdonderzoeker:
- Toni P. Kilts
-
Sarasota, Florida, Verenigde Staten, 34243
- Werving
- Sarasota Memorial Health Care Center at University Parkway
-
Contact:
- Site Public Contact
- Telefoonnummer: 941-917-6519
-
Hoofdonderzoeker:
- Toni P. Kilts
-
Sarasota, Florida, Verenigde Staten, 34239
- Werving
- Florida Cancer Specialists - Sarasota Downtown
-
Contact:
- Site Public Contact
- Telefoonnummer: 239-274-9930
- E-mail: ClinicalTrials@FLCancer.com
-
Hoofdonderzoeker:
- Toni P. Kilts
-
Sarasota, Florida, Verenigde Staten, 34239
- Werving
- FPG - Surgical Oncology Clinics Gynecologic Oncology Surgery
-
Contact:
- Site Public Contact
- Telefoonnummer: 941-917-2225
- E-mail: Research-Institute@smh.com
-
Hoofdonderzoeker:
- Toni P. Kilts
-
Venice, Florida, Verenigde Staten, 34275
- Werving
- Florida Cancer Specialists - Venice Pinebrook
-
Contact:
- Site Public Contact
- Telefoonnummer: 239-274-9930
- E-mail: ClinicalTrials@FLCancer.com
-
Hoofdonderzoeker:
- Toni P. Kilts
-
-
Georgia
-
Atlanta, Georgia, Verenigde Staten, 30322
- Werving
- Emory University Hospital/Winship Cancer Institute
-
Hoofdonderzoeker:
- Kristen Starbuck
-
Contact:
- Site Public Contact
- Telefoonnummer: 404-778-1868
-
Atlanta, Georgia, Verenigde Staten, 30303
- Werving
- Grady Health System
-
Hoofdonderzoeker:
- Kristen Starbuck
-
Contact:
- Site Public Contact
- Telefoonnummer: 404-778-1868
-
Atlanta, Georgia, Verenigde Staten, 30308
- Werving
- Emory University Hospital Midtown
-
Hoofdonderzoeker:
- Kristen Starbuck
-
Contact:
- Site Public Contact
- Telefoonnummer: 888-946-7447
-
Augusta, Georgia, Verenigde Staten, 30912
- Werving
- Augusta University Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 706-721-2388
- E-mail: ga_cares@augusta.edu
-
Hoofdonderzoeker:
- Bunja J. Rungruang
-
Decatur, Georgia, Verenigde Staten, 30033
- Werving
- Emory Decatur Hospital
-
Hoofdonderzoeker:
- Kristen Starbuck
-
Contact:
- Site Public Contact
- Telefoonnummer: 440-778-1868
- E-mail: clinicaltrialsoncology@dekalbmedical.org
-
-
Hawaii
-
Honolulu, Hawaii, Verenigde Staten, 96826
- Werving
- Kapiolani Medical Center for Women and Children
-
Contact:
- Site Public Contact
- Telefoonnummer: 808-983-6090
-
Hoofdonderzoeker:
- Michael E. Carney
-
Honolulu, Hawaii, Verenigde Staten, 96813
- Werving
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Contact:
- Site Public Contact
- Telefoonnummer: 808-524-6115
- E-mail: i.webster@hawaiicancercare.com
-
Hoofdonderzoeker:
- Michael E. Carney
-
Honolulu, Hawaii, Verenigde Staten, 96813
- Werving
- Queen's Cancer Cenrer - POB I
-
Contact:
- Site Public Contact
- Telefoonnummer: 808-532-0315
-
Hoofdonderzoeker:
- Michael E. Carney
-
Honolulu, Hawaii, Verenigde Staten, 96813
- Werving
- Queen's Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 808-545-8548
-
Hoofdonderzoeker:
- Michael E. Carney
-
Honolulu, Hawaii, Verenigde Staten, 96817
- Werving
- Queen's Cancer Center - Kuakini
-
Contact:
- Site Public Contact
- Telefoonnummer: 808-531-8521
-
Hoofdonderzoeker:
- Michael E. Carney
-
Honolulu, Hawaii, Verenigde Staten, 96819
- Werving
- Kaiser Permanente Moanalua Medical Center
-
Hoofdonderzoeker:
- Juraj Kavecansky
-
Contact:
- Site Public Contact
- Telefoonnummer: 808-432-5195
- E-mail: shelley.a.clark@kp.org
-
‘Aiea, Hawaii, Verenigde Staten, 96701
- Werving
- Pali Momi Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 808-486-6000
-
Hoofdonderzoeker:
- Michael E. Carney
-
‘Aiea, Hawaii, Verenigde Staten, 96701
- Werving
- Queen's Cancer Center - Pearlridge
-
Contact:
- Site Public Contact
- Telefoonnummer: 808-487-7447
-
Hoofdonderzoeker:
- Michael E. Carney
-
‘Ewa Beach, Hawaii, Verenigde Staten, 96706
- Werving
- The Queen's Medical Center - West Oahu
-
Contact:
- Site Public Contact
- E-mail: rohta@queens.org
-
Hoofdonderzoeker:
- Michael E. Carney
-
-
Idaho
-
Coeur d'Alene, Idaho, Verenigde Staten, 83814
- Werving
- Kootenai Health - Coeur d'Alene
-
Hoofdonderzoeker:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Telefoonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Post Falls, Idaho, Verenigde Staten, 83854
- Werving
- Kootenai Clinic Cancer Services - Post Falls
-
Hoofdonderzoeker:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Telefoonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Sandpoint, Idaho, Verenigde Staten, 83864
- Werving
- Kootenai Clinic Cancer Services - Sandpoint
-
Hoofdonderzoeker:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Telefoonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
-
Illinois
-
Chicago, Illinois, Verenigde Staten, 60637
- Werving
- University of Chicago Comprehensive Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 773-702-8222
- E-mail: cancerclinicaltrials@bsd.uchicago.edu
-
Hoofdonderzoeker:
- Alyssa Bujnak
-
Chicago, Illinois, Verenigde Staten, 60611
- Werving
- Northwestern University
-
Contact:
- Site Public Contact
- Telefoonnummer: 312-695-1301
- E-mail: cancer@northwestern.edu
-
Hoofdonderzoeker:
- Emma Barber
-
Chicago, Illinois, Verenigde Staten, 60612
- Werving
- Rush MD Anderson Cancer Center
-
Hoofdonderzoeker:
- Alexander C. Cohen
-
Contact:
- Site Public Contact
- Telefoonnummer: 312-226-2371
- E-mail: Cancer_Studies@rush.edu
-
Danville, Illinois, Verenigde Staten, 61832
- Werving
- Carle at The Riverfront
-
Hoofdonderzoeker:
- Pratima Chalasani
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-446-5532
- E-mail: Research@Carle.com
-
DeKalb, Illinois, Verenigde Staten, 60115
- Werving
- Northwestern Medicine Cancer Center Kishwaukee
-
Contact:
- Site Public Contact
- Telefoonnummer: 630-352-5360
- E-mail: Donald.Smith3@nm.org
-
Hoofdonderzoeker:
- Emma Barber
-
Decatur, Illinois, Verenigde Staten, 62526
- Werving
- Cancer Care Specialists of Illinois - Decatur
-
Hoofdonderzoeker:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Telefoonnummer: 217-876-4762
- E-mail: morganthaler.jodi@mhsil.com
-
Decatur, Illinois, Verenigde Staten, 62526
- Werving
- Decatur Memorial Hospital
-
Hoofdonderzoeker:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Telefoonnummer: 217-876-4762
- E-mail: morganthaler.jodi@mhsil.com
-
Effingham, Illinois, Verenigde Staten, 62401
- Werving
- Carle Physician Group-Effingham
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-446-5532
- E-mail: Research@carle.com
-
Hoofdonderzoeker:
- Pratima Chalasani
-
Evanston, Illinois, Verenigde Staten, 60201
- Werving
- NorthShore University HealthSystem-Evanston Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 847-570-2109
-
Hoofdonderzoeker:
- Mary T. Jenkins Vogel
-
Geneva, Illinois, Verenigde Staten, 60134
- Werving
- Northwestern Medicine Cancer Center Delnor
-
Contact:
- Site Public Contact
- Telefoonnummer: 630-352-5360
- E-mail: Donald.Smith3@nm.org
-
Hoofdonderzoeker:
- Emma Barber
-
Glenview, Illinois, Verenigde Staten, 60026
- Werving
- NorthShore University HealthSystem-Glenbrook Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 847-570-2109
-
Hoofdonderzoeker:
- Mary T. Jenkins Vogel
-
Harvey, Illinois, Verenigde Staten, 60426
- Werving
- Ingalls Memorial Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 708-915-4673
- E-mail: clinicaltrials@ingalls.org
-
Hoofdonderzoeker:
- Ivy Abraham
-
Highland Park, Illinois, Verenigde Staten, 60035
- Werving
- NorthShore University HealthSystem-Highland Park Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 847-570-2109
-
Hoofdonderzoeker:
- Mary T. Jenkins Vogel
-
Mattoon, Illinois, Verenigde Staten, 61938
- Werving
- Carle Physician Group-Mattoon/Charleston
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-446-5532
- E-mail: Research@carle.com
-
Hoofdonderzoeker:
- Pratima Chalasani
-
New Lenox, Illinois, Verenigde Staten, 60451
- Werving
- UC Comprehensive Cancer Center at Silver Cross
-
Contact:
- Site Public Contact
- Telefoonnummer: 773-702-8222
- E-mail: cancerclinicaltrials@bsd.uchicago.edu
-
Hoofdonderzoeker:
- Alyssa Bujnak
-
Normal, Illinois, Verenigde Staten, 61761
- Werving
- Carle BroMenn Medical Center
-
Hoofdonderzoeker:
- Pratima Chalasani
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-446-5532
- E-mail: Research@Carle.com
-
Normal, Illinois, Verenigde Staten, 61761
- Werving
- Carle Cancer Institute Normal
-
Hoofdonderzoeker:
- Pratima Chalasani
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-446-5532
- E-mail: Research@Carle.com
-
O'Fallon, Illinois, Verenigde Staten, 62269
- Werving
- Cancer Care Center of O'Fallon
-
Hoofdonderzoeker:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Telefoonnummer: 217-876-4762
- E-mail: morganthaler.jodi@mhsil.com
-
O'Fallon, Illinois, Verenigde Staten, 62269
- Werving
- HSHS Saint Elizabeth's Hospital
-
Hoofdonderzoeker:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Telefoonnummer: 217-876-4762
- E-mail: morganthaler.jodi@mhsil.com
-
Oak Brook, Illinois, Verenigde Staten, 60523
- Werving
- Northwestern Medicine Oak Brook
-
Hoofdonderzoeker:
- Emma Barber
-
Contact:
- Site Public Contact
- E-mail: nctnprogram_rhlccc@northwestern.edu
-
Oak Park, Illinois, Verenigde Staten, 60304
- Werving
- Rush MD Anderson Cancer Center at Rush Oak Park
-
Hoofdonderzoeker:
- Alexander C. Cohen
-
Contact:
- Site Public Contact
- Telefoonnummer: 312-226-2371
- E-mail: Cancer_Studies@rush.edu
-
Orland Park, Illinois, Verenigde Staten, 60462
- Werving
- University of Chicago Medicine-Orland Park
-
Contact:
- Site Public Contact
- Telefoonnummer: 773-702-8222
- E-mail: cancerclinicaltrials@bsd.uchicago.edu
-
Hoofdonderzoeker:
- Alyssa Bujnak
-
Orland Park, Illinois, Verenigde Staten, 60462
- Werving
- Northwestern Medicine Orland Park
-
Hoofdonderzoeker:
- Emma Barber
-
Contact:
- Site Public Contact
- E-mail: nctnprogram_rhlccc@northwestern.edu
-
Peoria, Illinois, Verenigde Staten, 61637
- Werving
- OSF Saint Francis Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 309-243-3605
- E-mail: andersonj@illinoiscancercare.com
-
Hoofdonderzoeker:
- Bryan A. Faller
-
Springfield, Illinois, Verenigde Staten, 62702
- Werving
- Southern Illinois University School of Medicine
-
Hoofdonderzoeker:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Telefoonnummer: 217-545-7929
-
Springfield, Illinois, Verenigde Staten, 62702
- Werving
- Springfield Clinic
-
Hoofdonderzoeker:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-444-7541
-
Springfield, Illinois, Verenigde Staten, 62781
- Werving
- Springfield Memorial Hospital
-
Hoofdonderzoeker:
- Bryan A. Faller
-
Contact:
- Site Public Contact
- Telefoonnummer: 217-528-7541
- E-mail: pallante.beth@mhsil.com
-
Urbana, Illinois, Verenigde Staten, 61801
- Werving
- Carle Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-446-5532
- E-mail: Research@carle.com
-
Hoofdonderzoeker:
- Pratima Chalasani
-
Warrenville, Illinois, Verenigde Staten, 60555
- Werving
- Northwestern Medicine Cancer Center Warrenville
-
Contact:
- Site Public Contact
- Telefoonnummer: 630-352-5360
- E-mail: Donald.Smith3@nm.org
-
Hoofdonderzoeker:
- Emma Barber
-
-
Indiana
-
Crown Point, Indiana, Verenigde Staten, 46307
- Werving
- UChicago Medicine Northwest Indiana
-
Contact:
- Site Public Contact
- Telefoonnummer: 855-702-8222
- E-mail: cancerclinicaltrials@bsd.uchicago.edu
-
Hoofdonderzoeker:
- Alyssa Bujnak
-
Goshen, Indiana, Verenigde Staten, 46526
- Werving
- Goshen Center for Cancer Care
-
Contact:
- Site Public Contact
- Telefoonnummer: 574-364-2973
- E-mail: cccois@goshenhealth.com
-
Hoofdonderzoeker:
- Pamela J. Stone
-
Indianapolis, Indiana, Verenigde Staten, 46260
- Werving
- Ascension Saint Vincent Indianapolis Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 317-338-2194
- E-mail: research@stvincent.org
-
Hoofdonderzoeker:
- Megan E. Buechel
-
South Bend, Indiana, Verenigde Staten, 46601
- Geschorst
- Memorial Hospital of South Bend
-
-
Iowa
-
Ankeny, Iowa, Verenigde Staten, 50023
- Werving
- UI Health Care Mission Cancer and Blood - Ankeny Clinic
-
Contact:
- Site Public Contact
- Telefoonnummer: 515-241-3305
-
Hoofdonderzoeker:
- Seema Harichand-Herdt
-
Carroll, Iowa, Verenigde Staten, 51401
- Werving
- Saint Anthony Regional Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 515-689-7658
- E-mail: sbenson@iora.org
-
Hoofdonderzoeker:
- Seema Harichand-Herdt
-
Cedar Rapids, Iowa, Verenigde Staten, 52403
- Werving
- Mercy Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 319-365-4673
-
Hoofdonderzoeker:
- Deborah W. Wilbur
-
Cedar Rapids, Iowa, Verenigde Staten, 52403
- Werving
- Oncology Associates at Mercy Medical Center
-
Hoofdonderzoeker:
- Deborah W. Wilbur
-
Contact:
- Site Public Contact
- Telefoonnummer: 319-363-2690
-
Clive, Iowa, Verenigde Staten, 50325
- Werving
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Contact:
- Site Public Contact
- Telefoonnummer: 515-241-3305
-
Hoofdonderzoeker:
- Seema Harichand-Herdt
-
Des Moines, Iowa, Verenigde Staten, 50314
- Werving
- Broadlawns Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 515-282-2200
-
Hoofdonderzoeker:
- Seema Harichand-Herdt
-
Des Moines, Iowa, Verenigde Staten, 50314
- Werving
- Mercy Medical Center - Des Moines
-
Contact:
- Site Public Contact
- Telefoonnummer: 515-241-3305
-
Hoofdonderzoeker:
- Richard L. Deming
-
Des Moines, Iowa, Verenigde Staten, 50309
- Werving
- Iowa Methodist Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 515-241-6727
-
Hoofdonderzoeker:
- Seema Harichand-Herdt
-
Des Moines, Iowa, Verenigde Staten, 50309
- Werving
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Contact:
- Site Public Contact
- Telefoonnummer: 515-241-3305
-
Hoofdonderzoeker:
- Seema Harichand-Herdt
-
Des Moines, Iowa, Verenigde Staten, 50314
- Werving
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
Contact:
- Site Public Contact
- Telefoonnummer: 515-241-3305
-
Hoofdonderzoeker:
- Seema Harichand-Herdt
-
Fort Dodge, Iowa, Verenigde Staten, 50501
- Werving
- UI Healthcare Mission Cancer and Blood - Fort Dodge
-
Hoofdonderzoeker:
- Seema Harichand-Herdt
-
Contact:
- Site Public Contact
- Telefoonnummer: 515-282-2921
- E-mail: trials@missioncancer.com
-
Iowa City, Iowa, Verenigde Staten, 52242
- Werving
- University of Iowa/Holden Comprehensive Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-237-1225
-
Hoofdonderzoeker:
- David P. Bender
-
Waukee, Iowa, Verenigde Staten, 50263
- Werving
- UI Health Care Mission Cancer and Blood - Waukee Clinic
-
Contact:
- Site Public Contact
- Telefoonnummer: 515-241-3305
-
Hoofdonderzoeker:
- Seema Harichand-Herdt
-
-
Kentucky
-
Lexington, Kentucky, Verenigde Staten, 40536
- Werving
- University of Kentucky/Markey Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 859-257-3379
-
Hoofdonderzoeker:
- Rachel W. Miller
-
Lexington, Kentucky, Verenigde Staten, 40503
- Werving
- Baptist Health Lexington
-
Contact:
- Site Public Contact
- Telefoonnummer: 859-260-6425
-
Hoofdonderzoeker:
- Hope Cottrill
-
-
Louisiana
-
Marrero, Louisiana, Verenigde Staten, 70072
- Werving
- West Jefferson Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 504-210-3539
- E-mail: emede1@lsuhsc.edu
-
Hoofdonderzoeker:
- Tara Castellano
-
Metairie, Louisiana, Verenigde Staten, 70006
- Werving
- East Jefferson General Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 504-210-3539
- E-mail: emede1@lsuhsc.edu
-
Hoofdonderzoeker:
- Tara Castellano
-
Metairie, Louisiana, Verenigde Staten, 70006
- Werving
- LSU Healthcare Network / Metairie Multi-Specialty Clinic
-
Contact:
- Site Public Contact
- Telefoonnummer: 504-210-3539
- E-mail: emede1@lsuhsc.edu
-
Hoofdonderzoeker:
- Tara Castellano
-
New Orleans, Louisiana, Verenigde Staten, 70112
- Werving
- University Medical Center New Orleans
-
Contact:
- Site Public Contact
- Telefoonnummer: 504-210-3539
- E-mail: emede1@lsuhsc.edu
-
Hoofdonderzoeker:
- Tara Castellano
-
-
Maine
-
Brewer, Maine, Verenigde Staten, 04412
- Werving
- Lafayette Family Cancer Center-EMMC
-
Hoofdonderzoeker:
- Sarah J. Sinclair
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-987-3005
-
Scarborough, Maine, Verenigde Staten, 04074
- Werving
- MaineHealth Maine Medical Center- Scarborough
-
Hoofdonderzoeker:
- Leslie S. Bradford
-
Contact:
- Site Public Contact
- Telefoonnummer: 207-396-8670
- E-mail: clinicalresearch@mainehealth.org
-
-
Maryland
-
Baltimore, Maryland, Verenigde Staten, 21287
- Werving
- Johns Hopkins University/Sidney Kimmel Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 410-955-8804
- E-mail: jhcccro@jhmi.edu
-
Hoofdonderzoeker:
- Amanda N. Fader
-
Baltimore, Maryland, Verenigde Staten, 21237
- Werving
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute
-
Hoofdonderzoeker:
- Ebony R. Hoskins
-
Contact:
- Site Public Contact
- Telefoonnummer: 443-777-7364
-
-
Massachusetts
-
Boston, Massachusetts, Verenigde Staten, 02215
- Werving
- Dana-Farber Cancer Institute
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-442-3324
-
Hoofdonderzoeker:
- Susana M. Campos
-
Burlington, Massachusetts, Verenigde Staten, 01805
- Werving
- Lahey Clinic
-
Contact:
- Site Public Contact
- Telefoonnummer: 781-744-3421
- E-mail: lhmc-cancer-clinical-trials@lahey.org
-
Hoofdonderzoeker:
- Corrine L. Zarwan
-
Peabody, Massachusetts, Verenigde Staten, 01960
- Werving
- Lahey Clinic Peabody
-
Contact:
- Site Public Contact
- Telefoonnummer: 781-744-3421
- E-mail: lhmc-cancer-clinical-trials@lahey.org
-
Hoofdonderzoeker:
- Corrine L. Zarwan
-
-
Michigan
-
Ann Arbor, Michigan, Verenigde Staten, 48109
- Werving
- University of Michigan Rogel Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-865-1125
- E-mail: CancerAnswerLine@med.umich.edu
-
Hoofdonderzoeker:
- Zhen Ni Zhou
-
Battle Creek, Michigan, Verenigde Staten, 49017
- Werving
- Bronson Battle Creek
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
- E-mail: crcwm-regulatory@crcwm.org
-
Hoofdonderzoeker:
- Kathleen Y. Butler
-
Brighton, Michigan, Verenigde Staten, 48114
- Werving
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Contact:
- Site Public Contact
- Telefoonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Hoofdonderzoeker:
- J. R. Liu
-
Brighton, Michigan, Verenigde Staten, 48116
- Werving
- University of Michigan - Brighton Center for Specialty Care
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-865-1125
-
Hoofdonderzoeker:
- Zhen Ni Zhou
-
Canton, Michigan, Verenigde Staten, 48188
- Werving
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Contact:
- Site Public Contact
- Telefoonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Hoofdonderzoeker:
- J. R. Liu
-
Chelsea, Michigan, Verenigde Staten, 48118
- Werving
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Hoofdonderzoeker:
- J. R. Liu
-
Detroit, Michigan, Verenigde Staten, 48201
- Werving
- Wayne State University/Karmanos Cancer Institute
-
Hoofdonderzoeker:
- Radhika P. Gogoi
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-527-6266
- E-mail: ctoadmin@karmanos.org
-
Escanaba, Michigan, Verenigde Staten, 49829
- Werving
- OSF Saint Francis Hospital and Medical Group
-
Hoofdonderzoeker:
- Matthew L. Ryan
-
Contact:
- Site Public Contact
- Telefoonnummer: 920-433-8889
- E-mail: WI_research_admin@hshs.org
-
Farmington Hills, Michigan, Verenigde Staten, 48334
- Werving
- Weisberg Cancer Treatment Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 313-576-9790
- E-mail: ctoadmin@karmanos.org
-
Hoofdonderzoeker:
- Radhika P. Gogoi
-
Flint, Michigan, Verenigde Staten, 48503
- Werving
- Genesys Hurley Cancer Institute
-
Contact:
- Site Public Contact
- Telefoonnummer: 810-762-8038
- E-mail: wstrong@ghci.org
-
Hoofdonderzoeker:
- J. R. Liu
-
Flint, Michigan, Verenigde Staten, 48503
- Werving
- Hurley Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 810-762-8038
- E-mail: wstrong@ghci.org
-
Hoofdonderzoeker:
- J. R. Liu
-
Flint, Michigan, Verenigde Staten, 48503
- Werving
- Cancer Hematology Centers - Flint
-
Contact:
- Site Public Contact
- Telefoonnummer: 810-762-8038
- E-mail: wstrong@ghci.org
-
Hoofdonderzoeker:
- J. R. Liu
-
Grand Rapids, Michigan, Verenigde Staten, 49503
- Werving
- Trinity Health Grand Rapids Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
- E-mail: crcwm-regulatory@crcwm.org
-
Hoofdonderzoeker:
- J. R. Liu
-
Grand Rapids, Michigan, Verenigde Staten, 49503
- Werving
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
- E-mail: crcwm-regulatory@crcwm.org
-
Hoofdonderzoeker:
- Kathleen Y. Butler
-
Kalamazoo, Michigan, Verenigde Staten, 49007
- Werving
- Bronson Methodist Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
- E-mail: crcwm-regulatory@crcwm.org
-
Hoofdonderzoeker:
- Kathleen Y. Butler
-
Kalamazoo, Michigan, Verenigde Staten, 49007
- Werving
- West Michigan Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
- E-mail: crcwm-regulatory@crcwm.org
-
Hoofdonderzoeker:
- Kathleen Y. Butler
-
Kalamazoo, Michigan, Verenigde Staten, 49009
- Werving
- Beacon Kalamazoo Cancer Center
-
Hoofdonderzoeker:
- Kathleen Y. Butler
-
Contact:
- Site Public Contact
- Telefoonnummer: 574-647-7370
-
Lansing, Michigan, Verenigde Staten, 48912
- Werving
- University of Michigan Health - Sparrow Lansing
-
Hoofdonderzoeker:
- J. R. Liu
-
Contact:
- Site Public Contact
- Telefoonnummer: 517-364-3712
- E-mail: harsha.trivedi@umhsparrow.org
-
Livonia, Michigan, Verenigde Staten, 48154
- Werving
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Hoofdonderzoeker:
- J. R. Liu
-
Manistique, Michigan, Verenigde Staten, 49854
- Werving
- Schoolcraft Memorial Hospital
-
Hoofdonderzoeker:
- Matthew L. Ryan
-
Contact:
- Site Public Contact
- Telefoonnummer: 920-433-8889
- E-mail: WI_research_admin@hshs.org
-
Muskegon, Michigan, Verenigde Staten, 49444
- Werving
- Trinity Health Muskegon Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
- E-mail: crcwm-regulatory@crcwm.org
-
Hoofdonderzoeker:
- J. R. Liu
-
Niles, Michigan, Verenigde Staten, 49120
- Werving
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
-
Hoofdonderzoeker:
- Kathleen Y. Butler
-
Norton Shores, Michigan, Verenigde Staten, 49444
- Werving
- Cancer and Hematology Centers of Western Michigan - Norton Shores
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
- E-mail: connie.szczepanek@crcwm.org
-
Hoofdonderzoeker:
- J. R. Liu
-
Pontiac, Michigan, Verenigde Staten, 48341
- Werving
- Trinity Health Saint Joseph Mercy Oakland Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Hoofdonderzoeker:
- J. R. Liu
-
Reed City, Michigan, Verenigde Staten, 49677
- Werving
- Corewell Health Reed City Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
- E-mail: crcwm-regulatory@crcwm.org
-
Hoofdonderzoeker:
- Kathleen Y. Butler
-
Saint Joseph, Michigan, Verenigde Staten, 49085
- Werving
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
- E-mail: crcwm-regulatory@crcwm.org
-
Hoofdonderzoeker:
- Kathleen Y. Butler
-
Saint Joseph, Michigan, Verenigde Staten, 49085
- Werving
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
- E-mail: crcwm-regulatory@crcwm.org
-
Hoofdonderzoeker:
- Kathleen Y. Butler
-
Traverse City, Michigan, Verenigde Staten, 49684
- Werving
- Munson Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
- E-mail: crcwm-regulatory@crcwm.org
-
Hoofdonderzoeker:
- Kathleen Y. Butler
-
Wyoming, Michigan, Verenigde Staten, 49519
- Werving
- University of Michigan Health - West
-
Contact:
- Site Public Contact
- Telefoonnummer: 616-391-1230
- E-mail: crcwm-regulatory@crcwm.org
-
Hoofdonderzoeker:
- Kathleen Y. Butler
-
Ypsilanti, Michigan, Verenigde Staten, 48197
- Werving
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
Contact:
- Site Public Contact
- Telefoonnummer: 734-712-7251
- E-mail: MCRCwebsitecontactform@stjoeshealth.org
-
Hoofdonderzoeker:
- J. R. Liu
-
-
Minnesota
-
Brainerd, Minnesota, Verenigde Staten, 56401
- Werving
- Essentia Health Saint Joseph's Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Hoofdonderzoeker:
- Bret E. Friday
-
Coon Rapids, Minnesota, Verenigde Staten, 55433
- Werving
- Mercy Hospital
-
Hoofdonderzoeker:
- Joleen M. Hubbard
-
Contact:
- Site Public Contact
- Telefoonnummer: 952-993-1517
- E-mail: mmcorc@healthpartners.com
-
Deer River, Minnesota, Verenigde Staten, 56636
- Werving
- Essentia Health - Deer River Clinic
-
Contact:
- Site Public Contact
- Telefoonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Hoofdonderzoeker:
- Bret E. Friday
-
Duluth, Minnesota, Verenigde Staten, 55805
- Werving
- Essentia Health Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Hoofdonderzoeker:
- Bret E. Friday
-
Edina, Minnesota, Verenigde Staten, 55435
- Werving
- Fairview Southdale Hospital
-
Hoofdonderzoeker:
- Joleen M. Hubbard
-
Contact:
- Site Public Contact
- Telefoonnummer: 952-993-1517
- E-mail: mmcorc@healthpartners.com
-
Edina, Minnesota, Verenigde Staten, 55435
- Werving
- Minnesota Oncology - Edina
-
Hoofdonderzoeker:
- Joleen M. Hubbard
-
Contact:
- Site Public Contact
- Telefoonnummer: 952-993-1517
- E-mail: mmcorc@healthpartners.com
-
Hibbing, Minnesota, Verenigde Staten, 55746
- Werving
- Essentia Health Hibbing Clinic
-
Hoofdonderzoeker:
- Bret E. Friday
-
Contact:
- Site Public Contact
- Telefoonnummer: 218-786-3308
-
Minneapolis, Minnesota, Verenigde Staten, 55407
- Werving
- Abbott-Northwestern Hospital
-
Hoofdonderzoeker:
- Joleen M. Hubbard
-
Contact:
- Site Public Contact
- Telefoonnummer: 952-993-1517
- E-mail: mmcorc@healthpartners.com
-
Minneapolis, Minnesota, Verenigde Staten, 55455
- Werving
- University of Minnesota/Masonic Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 612-624-2620
-
Hoofdonderzoeker:
- Alexandra Schefter
-
Saint Louis Park, Minnesota, Verenigde Staten, 55416
- Werving
- Park Nicollet Clinic - Saint Louis Park
-
Hoofdonderzoeker:
- Joleen M. Hubbard
-
Contact:
- Site Public Contact
- Telefoonnummer: 952-993-1517
- E-mail: mmcorc@healthpartners.com
-
Saint Paul, Minnesota, Verenigde Staten, 55101
- Werving
- Regions Hospital
-
Hoofdonderzoeker:
- Joleen M. Hubbard
-
Contact:
- Site Public Contact
- Telefoonnummer: 952-993-1517
- E-mail: mmcorc@healthpartners.com
-
Saint Paul, Minnesota, Verenigde Staten, 55102
- Werving
- United Hospital
-
Hoofdonderzoeker:
- Joleen M. Hubbard
-
Contact:
- Site Public Contact
- Telefoonnummer: 952-993-1517
- E-mail: mmcorc@healthpartners.com
-
Sandstone, Minnesota, Verenigde Staten, 55072
- Werving
- Essentia Health Sandstone
-
Contact:
- Site Public Contact
- Telefoonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Hoofdonderzoeker:
- Bret E. Friday
-
Virginia, Minnesota, Verenigde Staten, 55792
- Werving
- Essentia Health Virginia Clinic
-
Contact:
- Site Public Contact
- Telefoonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Hoofdonderzoeker:
- Bret E. Friday
-
Woodbury, Minnesota, Verenigde Staten, 55125
- Werving
- Minnesota Oncology Hematology PA-Woodbury
-
Hoofdonderzoeker:
- Joleen M. Hubbard
-
Contact:
- Site Public Contact
- Telefoonnummer: 952-993-1517
- E-mail: mmcorc@healthpartners.com
-
-
Missouri
-
Columbia, Missouri, Verenigde Staten, 65212
- Werving
- MU Health - University Hospital/Ellis Fischel Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 573-882-7440
-
Hoofdonderzoeker:
- Erin R. Tuller
-
Springfield, Missouri, Verenigde Staten, 65804
- Werving
- Mercy Hospital Springfield
-
Hoofdonderzoeker:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Telefoonnummer: 417-269-4520
-
Springfield, Missouri, Verenigde Staten, 65807
- Werving
- CoxHealth South Hospital
-
Hoofdonderzoeker:
- Jay W. Carlson
-
Contact:
- Site Public Contact
- Telefoonnummer: 417-269-4520
-
St Louis, Missouri, Verenigde Staten, 63110
- Werving
- Washington University School of Medicine
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-600-3606
- E-mail: info@siteman.wustl.edu
-
Hoofdonderzoeker:
- David G. Mutch
-
-
Montana
-
Anaconda, Montana, Verenigde Staten, 59711
- Werving
- Community Hospital of Anaconda
-
Hoofdonderzoeker:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Telefoonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Billings, Montana, Verenigde Staten, 59101
- Werving
- Billings Clinic Cancer Center
-
Hoofdonderzoeker:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-996-2663
- E-mail: research@billingsclinic.org
-
Billings, Montana, Verenigde Staten, 59102
- Werving
- Saint Vincent Frontier Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-648-6274
-
Hoofdonderzoeker:
- Megan Petersen
-
Billings, Montana, Verenigde Staten, 59106
- Werving
- Intermountain Health West End Clinic
-
Contact:
- Site Public Contact
- Telefoonnummer: 406-238-6685
-
Hoofdonderzoeker:
- Megan Petersen
-
Bozeman, Montana, Verenigde Staten, 59715
- Werving
- Bozeman Health Deaconess Hospital
-
Hoofdonderzoeker:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Telefoonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Great Falls, Montana, Verenigde Staten, 59405
- Werving
- Benefis Sletten Cancer Institute
-
Hoofdonderzoeker:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Telefoonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Kalispell, Montana, Verenigde Staten, 59901
- Werving
- Logan Health Medical Center
-
Hoofdonderzoeker:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Telefoonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
Missoula, Montana, Verenigde Staten, 59804
- Werving
- Community Medical Center
-
Hoofdonderzoeker:
- John M. Schallenkamp
-
Contact:
- Site Public Contact
- Telefoonnummer: 406-969-6060
- E-mail: mccinfo@mtcancer.org
-
-
Nebraska
-
Bellevue, Nebraska, Verenigde Staten, 68123
- Werving
- Nebraska Medicine-Bellevue
-
Contact:
- Site Public Contact
- Telefoonnummer: 402-559-6941
- E-mail: unmcrsa@unmc.edu
-
Hoofdonderzoeker:
- Lindsey A. McAlarnen
-
Kearney, Nebraska, Verenigde Staten, 68845
- Werving
- Fred and Pamela Buffett Cancer Center - Kearney
-
Contact:
- Site Public Contact
- Telefoonnummer: 402-559-6941
- E-mail: unmcrsa@unmc.edu
-
Hoofdonderzoeker:
- Lindsey A. McAlarnen
-
Omaha, Nebraska, Verenigde Staten, 68198
- Werving
- University of Nebraska Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 402-559-6941
- E-mail: unmcrsa@unmc.edu
-
Hoofdonderzoeker:
- Lindsey A. McAlarnen
-
Omaha, Nebraska, Verenigde Staten, 68114
- Werving
- Nebraska Methodist Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 402-354-5144
-
Hoofdonderzoeker:
- Brent J. Tierney
-
Omaha, Nebraska, Verenigde Staten, 68118
- Werving
- Nebraska Medicine-Village Pointe
-
Contact:
- Site Public Contact
- Telefoonnummer: 402-559-5600
-
Hoofdonderzoeker:
- Lindsey A. McAlarnen
-
-
Nevada
-
Las Vegas, Nevada, Verenigde Staten, 89106
- Werving
- Women's Cancer Center of Nevada
-
Hoofdonderzoeker:
- Nicola M. Spirtos
-
Contact:
- Site Public Contact
- Telefoonnummer: 702-851-4672
-
-
New Jersey
-
Basking Ridge, New Jersey, Verenigde Staten, 07920
- Werving
- Memorial Sloan Kettering Basking Ridge
-
Contact:
- Site Public Contact
- Telefoonnummer: 212-639-7592
-
Hoofdonderzoeker:
- Carol Aghajanian
-
Camden, New Jersey, Verenigde Staten, 08103
- Werving
- Cooper Hospital University Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 856-325-6757
-
Hoofdonderzoeker:
- Courtney Griffiths
-
Livingston, New Jersey, Verenigde Staten, 07039
- Werving
- Cooperman Barnabas Medical Center
-
Hoofdonderzoeker:
- Eugenia Girda
-
Contact:
- Site Public Contact
- Telefoonnummer: 973-322-5200
-
Middletown, New Jersey, Verenigde Staten, 07748
- Werving
- Memorial Sloan Kettering Monmouth
-
Contact:
- Site Public Contact
- Telefoonnummer: 212-639-7592
-
Hoofdonderzoeker:
- Carol Aghajanian
-
Montvale, New Jersey, Verenigde Staten, 07645
- Werving
- Memorial Sloan Kettering Bergen
-
Contact:
- Site Public Contact
- Telefoonnummer: 212-639-7592
-
Hoofdonderzoeker:
- Carol Aghajanian
-
New Brunswick, New Jersey, Verenigde Staten, 08903
- Werving
- Rutgers Cancer Institute of New Jersey
-
Contact:
- Site Public Contact
- Telefoonnummer: 732-235-7356
-
Hoofdonderzoeker:
- Eugenia Girda
-
Newark, New Jersey, Verenigde Staten, 07101
- Werving
- Rutgers New Jersey Medical School
-
Contact:
- Site Public Contact
- Telefoonnummer: 732-235-7356
-
Hoofdonderzoeker:
- Eugenia Girda
-
Paramus, New Jersey, Verenigde Staten, 07652
- Werving
- The Valley Hospital - Luckow Pavilion
-
Hoofdonderzoeker:
- Eleonora Teplinsky
-
Contact:
- Site Public Contact
- Telefoonnummer: 201-634-5792
- E-mail: clinicaltrialsresearch@valleyhealth.com
-
Ridgewood, New Jersey, Verenigde Staten, 07450
- Werving
- Valley Health System Ridgewood Campus
-
Hoofdonderzoeker:
- Eleonora Teplinsky
-
Contact:
- Site Public Contact
- Telefoonnummer: 201-634-5792
- E-mail: clinicaltrialsresearch@valleyhealth.com
-
Sewell, New Jersey, Verenigde Staten, 08080
- Werving
- Sidney Kimmel Cancer Center Washington Township
-
Contact:
- Site Public Contact
- Telefoonnummer: 215-600-9151
- E-mail: ONCTrialNow@jefferson.edu
-
Hoofdonderzoeker:
- Jessa Suhner
-
-
New Mexico
-
Albuquerque, New Mexico, Verenigde Staten, 87106
- Werving
- University of New Mexico Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 505-925-0348
- E-mail: HSC-ClinicalTrialInfo@salud.unm.edu
-
Hoofdonderzoeker:
- Amaranta D. Craig
-
-
New York
-
Bay Shore, New York, Verenigde Staten, 11706
- Werving
- Northwell Health Imbert Cancer Center
-
Hoofdonderzoeker:
- Veena S. John
-
Contact:
- Site Public Contact
- Telefoonnummer: 516-734-8896
-
Commack, New York, Verenigde Staten, 11725
- Werving
- Memorial Sloan Kettering Commack
-
Contact:
- Site Public Contact
- Telefoonnummer: 212-639-7592
-
Hoofdonderzoeker:
- Carol Aghajanian
-
Flushing, New York, Verenigde Staten, 11354
- Werving
- Northwell Health Physician Partners at Flushing
-
Hoofdonderzoeker:
- Veena S. John
-
Contact:
- Site Public Contact
- Telefoonnummer: 718-559-3600
- E-mail: nhppflushing@northwell.edu
-
Greenlawn, New York, Verenigde Staten, 11740
- Werving
- Northwell Health Cancer Institute at Huntington
-
Hoofdonderzoeker:
- Veena S. John
-
Contact:
- Site Public Contact
- Telefoonnummer: 516-734-8896
-
Harrison, New York, Verenigde Staten, 10604
- Werving
- Memorial Sloan Kettering Westchester
-
Contact:
- Site Public Contact
- Telefoonnummer: 212-639-7592
-
Hoofdonderzoeker:
- Carol Aghajanian
-
Lake Success, New York, Verenigde Staten, 11042
- Werving
- Northwell Health/Center for Advanced Medicine
-
Hoofdonderzoeker:
- Veena S. John
-
Contact:
- Site Public Contact
- Telefoonnummer: 516-734-8896
-
New York, New York, Verenigde Staten, 10065
- Werving
- Memorial Sloan Kettering Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 212-639-7592
-
Hoofdonderzoeker:
- Carol Aghajanian
-
New York, New York, Verenigde Staten, 10011
- Werving
- Mount Sinai Chelsea
-
Hoofdonderzoeker:
- Stephanie V. Blank
-
Contact:
- Site Public Contact
- Telefoonnummer: 212-824-7309
- E-mail: CCTO@mssm.edu
-
New York, New York, Verenigde Staten, 10029
- Werving
- Mount Sinai Hospital
-
Hoofdonderzoeker:
- Stephanie V. Blank
-
Contact:
- Site Public Contact
- Telefoonnummer: 212-824-7309
- E-mail: CCTO@mssm.edu
-
New York, New York, Verenigde Staten, 10075
- Werving
- Lenox Hill Hospital
-
Hoofdonderzoeker:
- Veena S. John
-
Contact:
- Site Public Contact
- Telefoonnummer: 516-734-8896
-
New York, New York, Verenigde Staten, 10065
- Werving
- Manhattan Eye Ear and Throat Hospital
-
Hoofdonderzoeker:
- Veena S. John
-
Contact:
- Site Public Contact
- Telefoonnummer: 212-434-4460
-
New York, New York, Verenigde Staten, 10019
- Werving
- Mount Sinai West
-
Hoofdonderzoeker:
- Stephanie V. Blank
-
Contact:
- Site Public Contact
- Telefoonnummer: 212-824-7309
- E-mail: CCTO@mssm.edu
-
Rego Park, New York, Verenigde Staten, 11374
- Werving
- Queens Cancer Center
-
Hoofdonderzoeker:
- Veena S. John
-
Contact:
- Site Public Contact
- Telefoonnummer: 718-312-3446
-
Rochester, New York, Verenigde Staten, 14642
- Werving
- University of Rochester
-
Contact:
- Site Public Contact
- Telefoonnummer: 585-275-5830
-
Hoofdonderzoeker:
- Rachael Turner
-
Sleepy Hollow, New York, Verenigde Staten, 10591
- Werving
- Phelps Memorial Hospital Center
-
Hoofdonderzoeker:
- Veena S. John
-
Contact:
- Site Public Contact
- Telefoonnummer: 914-366-1600
-
Staten Island, New York, Verenigde Staten, 10305
- Werving
- Staten Island University Hospital
-
Hoofdonderzoeker:
- Veena S. John
-
Contact:
- Site Public Contact
- Telefoonnummer: 718-226-8888
-
Stony Brook, New York, Verenigde Staten, 11794
- Werving
- Stony Brook University Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-862-2215
-
Hoofdonderzoeker:
- Susan M. Lang
-
Syracuse, New York, Verenigde Staten, 13210
- Werving
- State University of New York Upstate Medical University
-
Contact:
- Site Public Contact
- Telefoonnummer: 315-464-5476
-
Hoofdonderzoeker:
- Mary J. Cunningham
-
The Bronx, New York, Verenigde Staten, 10461
- Werving
- Montefiore Medical Center-Einstein Campus
-
Contact:
- Site Public Contact
- Telefoonnummer: 718-379-6866
- E-mail: eskwak@montefiore.org
-
Hoofdonderzoeker:
- Nicole S. Nevadunsky
-
The Bronx, New York, Verenigde Staten, 10467
- Werving
- Montefiore Medical Center - Moses Campus
-
Contact:
- Site Public Contact
- Telefoonnummer: 718-379-6866
- E-mail: eskwak@montefiore.org
-
Hoofdonderzoeker:
- Nicole S. Nevadunsky
-
The Bronx, New York, Verenigde Staten, 10461
- Werving
- Montefiore Medical Center-Weiler Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 718-379-6866
- E-mail: eskwak@montefiore.org
-
Hoofdonderzoeker:
- Nicole S. Nevadunsky
-
Uniondale, New York, Verenigde Staten, 11553
- Werving
- Memorial Sloan Kettering Nassau
-
Contact:
- Site Public Contact
- Telefoonnummer: 212-639-7592
-
Hoofdonderzoeker:
- Carol Aghajanian
-
Webster, New York, Verenigde Staten, 14580
- Werving
- Wilmot Cancer Institute at Webster
-
Contact:
- Site Public Contact
- E-mail: WCICTOresearch@urmc.rochester.edu
-
Hoofdonderzoeker:
- Rachael Turner
-
-
North Carolina
-
Chapel Hill, North Carolina, Verenigde Staten, 27599
- Werving
- UNC Lineberger Comprehensive Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 877-668-0683
- E-mail: cancerclinicaltrials@med.unc.edu
-
Hoofdonderzoeker:
- Olivia D. Lara
-
Clinton, North Carolina, Verenigde Staten, 28328
- Werving
- Southeastern Medical Oncology Center-Clinton
-
Contact:
- Site Public Contact
- Telefoonnummer: 919-587-9084
- E-mail: jfields@cancersmoc.com
-
Hoofdonderzoeker:
- Samer S. Kasbari
-
Durham, North Carolina, Verenigde Staten, 27710
- Werving
- Duke University Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 888-275-3853
-
Hoofdonderzoeker:
- Jennifer L. McNally
-
Goldsboro, North Carolina, Verenigde Staten, 27534
- Werving
- Southeastern Medical Oncology Center-Goldsboro
-
Contact:
- Site Public Contact
- Telefoonnummer: 919-587-9084
- E-mail: jfields@cancersmoc.com
-
Hoofdonderzoeker:
- Samer S. Kasbari
-
Jacksonville, North Carolina, Verenigde Staten, 28546
- Werving
- Southeastern Medical Oncology Center-Jacksonville
-
Hoofdonderzoeker:
- Samer S. Kasbari
-
Contact:
- Site Public Contact
- Telefoonnummer: 910-587-9084
- E-mail: jfields@cancersmoc.com
-
Raleigh, North Carolina, Verenigde Staten, 27607
- Werving
- Duke Women's Cancer Care Raleigh
-
Contact:
- Site Public Contact
- Telefoonnummer: 919-785-4878
-
Hoofdonderzoeker:
- Jennifer L. McNally
-
-
North Dakota
-
Fargo, North Dakota, Verenigde Staten, 58103
- Werving
- Essentia Health Cancer Center-South University Clinic
-
Contact:
- Site Public Contact
- Telefoonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Hoofdonderzoeker:
- Bret E. Friday
-
-
Ohio
-
Athens, Ohio, Verenigde Staten, 45701
- Werving
- OhioHealth O'Bleness Hospital
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Beachwood, Ohio, Verenigde Staten, 44122
- Werving
- UHHS-Chagrin Highlands Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-641-2422
- E-mail: CTUReferral@UHhospitals.org
-
Hoofdonderzoeker:
- Amy Armstrong
-
Canton, Ohio, Verenigde Staten, 44710
- Werving
- Aultman Health Foundation
-
Contact:
- Site Public Contact
- Telefoonnummer: 330-363-7274
- E-mail: ClinicalReserachDept@aultman.com
-
Hoofdonderzoeker:
- Sunitha Vemulapalli
-
Chardon, Ohio, Verenigde Staten, 44024
- Werving
- Geauga Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-641-2422
- E-mail: CTUReferral@UHhospitals.org
-
Hoofdonderzoeker:
- Amy Armstrong
-
Cleveland, Ohio, Verenigde Staten, 44106
- Werving
- Case Western Reserve University
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-641-2422
- E-mail: CTUReferral@UHhospitals.org
-
Hoofdonderzoeker:
- Amy Armstrong
-
Columbus, Ohio, Verenigde Staten, 43214
- Werving
- Columbus Oncology and Hematology Associates Inc
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Columbus, Ohio, Verenigde Staten, 43214
- Werving
- Riverside Methodist Hospital
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Columbus, Ohio, Verenigde Staten, 43215
- Werving
- Grant Medical Center
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Columbus, Ohio, Verenigde Staten, 43228
- Werving
- Doctors Hospital
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Columbus, Ohio, Verenigde Staten, 43210
- Werving
- Ohio State University Comprehensive Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-293-5066
- E-mail: Jamesline@osumc.edu
-
Hoofdonderzoeker:
- Floor Backes
-
Delaware, Ohio, Verenigde Staten, 43015
- Werving
- Delaware Health Center-Grady Cancer Center
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Delaware, Ohio, Verenigde Staten, 43015
- Werving
- Grady Memorial Hospital
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Dublin, Ohio, Verenigde Staten, 43016
- Werving
- Columbus Oncology and Hematology Associates
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Dublin, Ohio, Verenigde Staten, 43016
- Werving
- Dublin Methodist Hospital
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Mansfield, Ohio, Verenigde Staten, 44903
- Werving
- OhioHealth Mansfield Hospital
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Marion, Ohio, Verenigde Staten, 43302
- Werving
- OhioHealth Marion General Hospital
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Mentor, Ohio, Verenigde Staten, 44060
- Werving
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-641-2422
- E-mail: CTUReferral@UHhospitals.org
-
Hoofdonderzoeker:
- Amy Armstrong
-
Parma, Ohio, Verenigde Staten, 44129
- Werving
- University Hospitals Parma Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-641-2422
- E-mail: CTUReferral@UHhospitals.org
-
Hoofdonderzoeker:
- Amy Armstrong
-
Pickerington, Ohio, Verenigde Staten, 43147
- Werving
- OhioHealth Pickerington Methodist Hospital
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 614-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Sylvania, Ohio, Verenigde Staten, 43560
- Werving
- ProMedica Flower Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 419-824-1842
- E-mail: PCIOncResearch@promedica.org
-
Hoofdonderzoeker:
- Anjalika Gandhi
-
Westerville, Ohio, Verenigde Staten, 43082
- Werving
- OhioHealth Westerville Medical Campus/Westerville Cancer Center
-
Hoofdonderzoeker:
- Aine E. Clements
-
Contact:
- Site Public Contact
- Telefoonnummer: 610-788-3860
- E-mail: Jennifer.Sexton@ohiohealth.com
-
Westlake, Ohio, Verenigde Staten, 44145
- Werving
- UH Seidman Cancer Center at Saint John Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-641-2422
- E-mail: CTUReferral@UHhospitals.org
-
Hoofdonderzoeker:
- Amy Armstrong
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Verenigde Staten, 73104
- Werving
- University of Oklahoma Health Sciences Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 405-271-8777
- E-mail: ou-clinical-trials@ouhsc.edu
-
Hoofdonderzoeker:
- Grace Duininck
-
-
Oregon
-
Portland, Oregon, Verenigde Staten, 97213
- Werving
- Providence Portland Medical Center
-
Hoofdonderzoeker:
- Dan S. Zuckerman
-
Contact:
- Site Public Contact
- Telefoonnummer: 503-215-2614
- E-mail: CanRsrchStudies@providence.org
-
Portland, Oregon, Verenigde Staten, 97225
- Werving
- Providence Saint Vincent Medical Center
-
Hoofdonderzoeker:
- Dan S. Zuckerman
-
Contact:
- Site Public Contact
- Telefoonnummer: 503-215-2614
- E-mail: CanRsrchStudies@providence.org
-
Portland, Oregon, Verenigde Staten, 97210
- Werving
- Legacy Good Samaritan Hospital and Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-220-4937
- E-mail: cancer@lhs.org
-
Hoofdonderzoeker:
- Julia Fehniger
-
Tualatin, Oregon, Verenigde Staten, 97062
- Werving
- Legacy Meridian Park Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 503-413-1742
-
Hoofdonderzoeker:
- Julia Fehniger
-
-
Pennsylvania
-
Erie, Pennsylvania, Verenigde Staten, 16505
- Werving
- UPMC Hillman Cancer Center Erie
-
Hoofdonderzoeker:
- Sarah E. Taylor
-
Contact:
- Site Public Contact
- Telefoonnummer: 412-864-7716
- E-mail: ClinicalResearchServices@upmc.edu
-
Greensburg, Pennsylvania, Verenigde Staten, 15601
- Werving
- UPMC Cancer Centers - Arnold Palmer Pavilion
-
Contact:
- Site Public Contact
- Telefoonnummer: 724-838-1900
-
Hoofdonderzoeker:
- Sarah E. Taylor
-
Hershey, Pennsylvania, Verenigde Staten, 17033-0850
- Werving
- Penn State Milton S Hershey Medical Center
-
Hoofdonderzoeker:
- Mark S. Shahin
-
Contact:
- Site Public Contact
- Telefoonnummer: 717-531-3779
- E-mail: CTO@hmc.psu.edu
-
Mechanicsburg, Pennsylvania, Verenigde Staten, 17050
- Werving
- UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
-
Contact:
- Site Public Contact
- Telefoonnummer: 412-389-5208
- E-mail: haneydl@upmc.edu
-
Hoofdonderzoeker:
- Sarah E. Taylor
-
Philadelphia, Pennsylvania, Verenigde Staten, 19107
- Werving
- Thomas Jefferson University Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 215-600-9151
- E-mail: ONCTrialNow@jefferson.edu
-
Hoofdonderzoeker:
- Jessa Suhner
-
Philadelphia, Pennsylvania, Verenigde Staten, 19114
- Werving
- Jefferson Torresdale Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 215-600-9151
- E-mail: ONCTrialNow@jefferson.edu
-
Hoofdonderzoeker:
- Jessa Suhner
-
Pittsburgh, Pennsylvania, Verenigde Staten, 15213
- Werving
- UPMC-Magee Womens Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 412-647-2811
-
Hoofdonderzoeker:
- Sarah E. Taylor
-
Pittsburgh, Pennsylvania, Verenigde Staten, 15237
- Werving
- UPMC-Passavant Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 412-367-6454
-
Hoofdonderzoeker:
- Sarah E. Taylor
-
Washington, Pennsylvania, Verenigde Staten, 15301
- Werving
- UPMC Cancer Center-Washington
-
Contact:
- Site Public Contact
- Telefoonnummer: 412-339-5294
- E-mail: Roster@nrgoncology.org
-
Hoofdonderzoeker:
- Sarah E. Taylor
-
Willow Grove, Pennsylvania, Verenigde Staten, 19090
- Werving
- Asplundh Cancer Pavilion
-
Contact:
- Site Public Contact
- Telefoonnummer: 215-600-9151
- E-mail: ONCTrialNow@jefferson.edu
-
Hoofdonderzoeker:
- Jessa Suhner
-
-
Rhode Island
-
Providence, Rhode Island, Verenigde Staten, 02903
- Werving
- Rhode Island Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 401-444-1488
-
Hoofdonderzoeker:
- Boris Martinez
-
Providence, Rhode Island, Verenigde Staten, 02905
- Werving
- Women and Infants Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 401-274-1122
-
Hoofdonderzoeker:
- Paul A. DiSilvestro
-
-
Tennessee
-
Franklin, Tennessee, Verenigde Staten, 37067
- Werving
- Vanderbilt-Ingram Cancer Center Cool Springs
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-811-8480
-
Hoofdonderzoeker:
- Alaina J. Brown
-
Nashville, Tennessee, Verenigde Staten, 37232
- Werving
- Vanderbilt University/Ingram Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-811-8480
-
Hoofdonderzoeker:
- Alaina J. Brown
-
Nashville, Tennessee, Verenigde Staten, 37204
- Werving
- Vanderbilt Breast Center at One Hundred Oaks
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-811-8480
-
Hoofdonderzoeker:
- Alaina J. Brown
-
-
Utah
-
Salt Lake City, Utah, Verenigde Staten, 84106
- Werving
- University of Utah Sugarhouse Health Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 888-424-2100
- E-mail: cancerinfo@hci.utah.edu
-
Hoofdonderzoeker:
- Talicia Savage
-
Salt Lake City, Utah, Verenigde Staten, 84112
- Werving
- Huntsman Cancer Institute/University of Utah
-
Contact:
- Site Public Contact
- Telefoonnummer: 888-424-2100
- E-mail: cancerinfo@hci.utah.edu
-
Hoofdonderzoeker:
- Talicia Savage
-
South Jordan, Utah, Verenigde Staten, 84009
- Werving
- South Jordan Health Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 888-424-2100
- E-mail: cancerinfo@hci.utah.edu
-
Hoofdonderzoeker:
- Talicia Savage
-
-
Virginia
-
Charlottesville, Virginia, Verenigde Staten, 22908
- Werving
- University of Virginia Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 434-243-6303
- E-mail: uvacancertrials@hscmail.mcc.virginia.edu
-
Hoofdonderzoeker:
- Matthew K. Wagar
-
Richmond, Virginia, Verenigde Staten, 23298
- Werving
- VCU Massey Comprehensive Cancer Center
-
Hoofdonderzoeker:
- Jaclyn Wall
-
Contact:
- Site Public Contact
- Telefoonnummer: 804-628-6430
- E-mail: CTOclinops@vcu.edu
-
-
Washington
-
Edmonds, Washington, Verenigde Staten, 98026
- Werving
- Swedish Cancer Institute-Edmonds
-
Hoofdonderzoeker:
- Dan S. Zuckerman
-
Contact:
- Site Public Contact
- Telefoonnummer: 206-215-2343
- E-mail: PCRC-NCORP@Swedish.org
-
Issaquah, Washington, Verenigde Staten, 98029
- Werving
- Swedish Cancer Institute-Issaquah
-
Hoofdonderzoeker:
- Dan S. Zuckerman
-
Contact:
- Site Public Contact
- Telefoonnummer: 206-215-2343
- E-mail: PCRC-NCORP@Swedish.org
-
Seattle, Washington, Verenigde Staten, 98122
- Werving
- Swedish Medical Center-First Hill
-
Hoofdonderzoeker:
- Dan S. Zuckerman
-
Contact:
- Site Public Contact
- Telefoonnummer: 206-215-2343
- E-mail: PCRC-NCORP@Swedish.org
-
Seattle, Washington, Verenigde Staten, 98195
- Werving
- University of Washington Medical Center - Montlake
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-804-8824
-
Hoofdonderzoeker:
- Heidi J. Gray
-
Seattle, Washington, Verenigde Staten, 98109
- Werving
- Fred Hutchinson Cancer Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 800-804-8824
-
Hoofdonderzoeker:
- Heidi J. Gray
-
Vancouver, Washington, Verenigde Staten, 98686
- Werving
- Legacy Salmon Creek Hospital
-
Contact:
- Site Public Contact
- Telefoonnummer: 503-413-2150
-
Hoofdonderzoeker:
- Julia Fehniger
-
-
West Virginia
-
Bridgeport, West Virginia, Verenigde Staten, 26330
- Werving
- United Hospital Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 304-293-7374
- E-mail: cancertrialsinfo@hsc.wvu.edu
-
Hoofdonderzoeker:
- Krista S. Pfaendler
-
Charleston, West Virginia, Verenigde Staten, 25304
- Werving
- Vandalia Health/CAMC Institute for Academic Medicine
-
Hoofdonderzoeker:
- Stephen H. Bush
-
Contact:
- Site Public Contact
- Telefoonnummer: 304-388-9944
- E-mail: CAMCClinicalTrials@vandaliahealth.org
-
Martinsburg, West Virginia, Verenigde Staten, 25401
- Werving
- WVUH-Berkely Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 304-293-7374
- E-mail: cancertrialsinfo@hsc.wvu.edu
-
Hoofdonderzoeker:
- Krista S. Pfaendler
-
Morgantown, West Virginia, Verenigde Staten, 26506
- Werving
- West Virginia University Healthcare
-
Contact:
- Site Public Contact
- Telefoonnummer: 304-293-7374
- E-mail: cancertrialsinfo@hsc.wvu.edu
-
Hoofdonderzoeker:
- Krista S. Pfaendler
-
Parkersburg, West Virginia, Verenigde Staten, 26101
- Werving
- Camden Clark Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 304-293-7374
- E-mail: cancertrialsinfo@hsc.wvu.edu
-
Hoofdonderzoeker:
- Krista S. Pfaendler
-
-
Wisconsin
-
Ashland, Wisconsin, Verenigde Staten, 54806
- Werving
- Duluth Clinic Ashland
-
Contact:
- Site Public Contact
- Telefoonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Hoofdonderzoeker:
- Bret E. Friday
-
Green Bay, Wisconsin, Verenigde Staten, 54301
- Werving
- Saint Vincent Hospital Cancer Center Green Bay
-
Hoofdonderzoeker:
- Matthew L. Ryan
-
Contact:
- Site Public Contact
- Telefoonnummer: 920-433-8889
- E-mail: WI_research_admin@hshs.org
-
Green Bay, Wisconsin, Verenigde Staten, 54303
- Werving
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Hoofdonderzoeker:
- Matthew L. Ryan
-
Contact:
- Site Public Contact
- Telefoonnummer: 920-433-8889
- E-mail: wi_research_admin@hshs.org
-
La Crosse, Wisconsin, Verenigde Staten, 54601
- Werving
- Gundersen Lutheran Medical Center
-
Contact:
- Site Public Contact
- Telefoonnummer: 608-775-2385
- E-mail: cancerctr@gundersenhealth.org
-
Hoofdonderzoeker:
- Gil Harmon
-
Milwaukee, Wisconsin, Verenigde Staten, 53226
- Werving
- Medical College of Wisconsin
-
Contact:
- Site Public Contact
- Telefoonnummer: 414-805-3666
-
Hoofdonderzoeker:
- William H. Bradley
-
Oconto Falls, Wisconsin, Verenigde Staten, 54154
- Werving
- Saint Vincent Hospital Cancer Center at Oconto Falls
-
Hoofdonderzoeker:
- Matthew L. Ryan
-
Contact:
- Site Public Contact
- Telefoonnummer: 920-433-8889
- E-mail: WI_research_admin@hshs.org
-
Sheboygan, Wisconsin, Verenigde Staten, 53081
- Werving
- Saint Vincent Hospital Cancer Center at Sheboygan
-
Hoofdonderzoeker:
- Matthew L. Ryan
-
Contact:
- Site Public Contact
- Telefoonnummer: 920-433-8889
- E-mail: wi_research_admin@hshs.org
-
Sheboygan, Wisconsin, Verenigde Staten, 53081
- Werving
- Sheboygan Physicians Group
-
Hoofdonderzoeker:
- Matthew L. Ryan
-
Contact:
- Site Public Contact
- Telefoonnummer: 920-433-8889
- E-mail: wi_research_admin@hshs.org
-
Spooner, Wisconsin, Verenigde Staten, 54801
- Werving
- Essentia Health-Spooner Clinic
-
Contact:
- Site Public Contact
- Telefoonnummer: 218-786-3308
- E-mail: CancerTrials@EssentiaHealth.org
-
Hoofdonderzoeker:
- Bret E. Friday
-
Sturgeon Bay, Wisconsin, Verenigde Staten, 54235-1495
- Werving
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
Hoofdonderzoeker:
- Matthew L. Ryan
-
Contact:
- Site Public Contact
- Telefoonnummer: 920-433-8889
- E-mail: wi_research_admin@hshs.org
-
Superior, Wisconsin, Verenigde Staten, 54880
- Werving
- Essentia Health Saint Mary's Hospital - Superior
-
Hoofdonderzoeker:
- Bret E. Friday
-
Contact:
- Site Public Contact
- Telefoonnummer: 701-364-6272
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
-
Documentation of disease:
- Stage III and stage IVA endometrial cancers (with measurable disease),
- Stage IVB endometrial cancer (with or without measurable disease), or
- Recurrent endometrial cancer (with or without measurable disease)
-
In patients with measurable disease, lesions will be defined and monitored by RECIST 1.1. Measurable disease (RECIST 1.1) is defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded). Each lesion must be ≥ 10 mm when measured by CT or MRI. Lymph nodes must be ≥ 15 mm in short axis when measured by CT or MRI
-
Histologic confirmation of the original primary tumor is required (submission of pathology report[s] is required). Patients with the following histologic types are eligible: endometrioid, serous, dedifferentiated/undifferentiated, clear cell, mixed epithelial, carcinosarcoma, adenocarcinoma not otherwise specified (N.O.S.)
-
Patients must have:
- Tumoral mismatch repair proficient (pMMR) disease as assessed by immunohistochemistry (IHC) AND
- P53 IHC with aberrant staining pattern (aberrant p53 expression is consistent with mutant TP53). TP53 mutation by next-generation sequencing will also be accepted
-
A pathology report demonstrating results of institutional MMR IHC and p53 IHC and/or TP53 by next-generation sequencing
-
Patients may have received:
- NO prior chemotherapy for treatment of endometrial cancer OR
- Prior adjuvant chemotherapy (e.g., paclitaxel/carboplatin alone or as a component of concurrent chemotherapy and radiation therapy [with or without cisplatin]) provided adjuvant chemotherapy was completed ≥ 12 months prior to registration
-
Patients may have received prior radiation therapy for treatment of endometrial cancer. Prior radiation therapy may have included pelvic radiation therapy, extended field pelvic/para-aortic radiation therapy, intravaginal brachytherapy, and/or palliative radiation therapy. All radiation therapy must be completed at least 4 weeks prior to registration. For patients with recent radiation, they must have RECIST-evaluable disease outside of the radiation field and have recovered their marrow function
-
Patients may have received prior hormonal (endocrine) therapy. All hormonal (endocrine) therapy must have been completed at least 1 week prior to registration
-
NO prior pembrolizumab (or other anti-PD1, anti-PDL1 or anti-CTLA4 therapy) or bevacizumab (or other antiangiogenic therapy)
-
Interval or cytoreductive surgery, after start of treatment on this trial, and prior to documentation of disease progression, is NOT permitted
-
Patients with treated brain metastases are eligible if follow-up brain imaging after central nervous system (CNS)-directed therapy shows no evidence of disease progression. Patients with brain metastases must have follow up imaging demonstrating no evidence of disease progression and that the disease is stable off of steroids
-
Age ≥ 18
-
Eastern Cooperative Oncology Group (ECOG) performance status of ≤ 2
-
Not pregnant and not nursing
-
Absolute neutrophil count (ANC) ≥ 1,500 cells/mm^3
-
Platelets ≥ 100,000 cells/mm^3
-
Hemoglobin ≥ 8 g/dl
-
Creatinine clearance (CrCl) of ≥ 30 mL/min by the Cockcroft-Gault formula
-
Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN) (patients with known Gilbert's disease who have bilirubin level ≤ 3 x institutional ULN may be enrolled)
-
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 x institutional ULN
-
Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class II or better
-
No active infection requiring parenteral antibiotics
-
No current evidence of intra-abdominal abscess, abdominal/pelvic fistula (not diverted), gastrointestinal perforation, gastrointestinal (GI) obstruction, and/or need for drainage nasogastric or gastrostomy tube
-
No clinically significant bleeding within 28 days prior to registration
-
No uncontrolled hypertension, defined as systolic ≥ 160 mm Hg or diastolic ≥ 100 mm Hg
-
No major surgery within 28 days of initiation of bevacizumab
-
No active autoimmune disease or history of autoimmune disease that might recur, which may affect vital organ function or require immune suppressive treatment including corticosteroids. This includes, but is not limited to, patients with a history of immune related neurologic disease, multiple sclerosis, autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis; systemic autoimmune disease such as systemic lupus erythematosus (SLE), connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or phospholipid syndrome because of the risk of recurrence or exacerbation of disease
- Patients with vitiligo, endocrine deficiencies including type I diabetes mellitus, thyroiditis managed with replacement hormones including physiologic corticosteroids are eligible
- Topical or inhaled steroids are allowed
- Patients with rheumatoid arthritis and other arthropathies, Sjogren's syndrome and psoriasis controlled with topical medication and patients with positive serology, such as antinuclear antibodies (ANA), and anti-thyroid antibodies should be evaluated with the presence of target organ involvement and potential need for systemic treatment but should otherwise be eligible
-
No history of (non-infectious) pneumonitis that required steroids, or current pneumonitis
-
No history of stem cell or solid organ transplant
-
No history of allergic reaction to the study agent(s) or compounds of similar chemical or biologic composition to the study agent(s) (or any of its excipients)
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Arm 1 (paclitaxel, carboplatin, pembrolizumab)
Patients receive paclitaxel IV over 3 hours, carboplatin IV and pembrolizumab IV over 30 minutes on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance pembrolizumab IV over 30 minutes on day 1 of each cycle. Cycles repeat every 6 weeks for up to an additional 14 cycles. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study. |
Given IV
Andere namen:
Given IV
Andere namen:
Undergo CT
Andere namen:
Undergo MRI
Andere namen:
Given IV
Andere namen:
Undergo urine and blood sample collection
Andere namen:
|
|
Experimenteel: Arm 2 (paclitaxel, carboplatin, bevacizumab)
Patients receive paclitaxel IV over 3 hours, carboplatin IV, and bevacizumab IV or anti-VEGF antibody biosimilar on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance bevacizumab IV on day 1 of each cycle. Treatment repeats every 3 weeks for up to an additional 28 doses. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study. |
Given IV
Andere namen:
Given IV
Andere namen:
Given IV
Andere namen:
Undergo CT
Andere namen:
Undergo MRI
Andere namen:
Undergo urine and blood sample collection
Andere namen:
|
|
Experimenteel: Arm 3 (paclitaxel, carboplatin, pembrolizumab, bevacizumab)
Patients receive paclitaxel IV over 3 hours, carboplatin IV, pembrolizumab IV over 30 minutes, and bevacizumab IV or anti-VEGF antibody biosimilar on day 1 of each cycle. Cycles repeat every 3 weeks for up to 6-10 cycles in the absence of disease progression or unacceptable toxicity. Starting 3 weeks after last combination phase cycle, patients may continue to receive maintenance pembrolizumab IV over 30 minutes every 6 weeks for up to an additional 14 cycles and bevacizumab IV every 3 weeks for up to an additional 28 doses. Additionally, patients undergo urine and blood sample collection and CT or MRI throughout the study. |
Given IV
Andere namen:
Given IV
Andere namen:
Given IV
Andere namen:
Undergo CT
Andere namen:
Undergo MRI
Andere namen:
Given IV
Andere namen:
Undergo urine and blood sample collection
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Progression-free survival (PFS)
Tijdsspanne: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years
|
Will be defined using Response Evaluation Criteria in Solid Tumors version (v) 1.1. Will be tested using one-sided log-rank tests with α-levels stratified by factors used in the randomization. Patients will be grouped by their randomized treatment assignment for intention-to-treat (ITT) analyses, supported by patients in ITT population. Treatment hazard ratios and their 95% confidence intervals will be estimated using a Cox proportional hazards models specified with a main effect for the randomized treatment assignment and stratified using the stratification factors applied at randomization. |
From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Overall survival (OS)
Tijdsspanne: From study entry to time of death from any cause, assessed up to 5 years
|
Will be assessed with proportional hazards modeling stratified for stratification factors at baseline. Hazard ratios and corresponding 2-sided 95% confidence intervals will be estimated for treatment (with Arm 1 as the reference arm). |
From study entry to time of death from any cause, assessed up to 5 years
|
|
Prognostic and predictive associations of type of TP53 mutation status with PFS
Tijdsspanne: Up to 5 years
|
Will be assessed with proportional hazards modeling stratified for stratification factors at baseline and adjusted by randomized treatment arm assignment. Hazard ratios and corresponding 2-sided 95% confidence intervals will be estimated for TP53 status as well as treatment hazard ratios (with Arm 1 as the reference arm) within TP53 subgroups. |
Up to 5 years
|
|
Prognostic and predictive associations of type of TP53 mutation status with OS
Tijdsspanne: Up to 5 years
|
Will be assessed with proportional hazards modeling stratified for stratification factors at baseline and adjusted by randomized treatment arm assignment. Hazard ratios and corresponding 2-sided 95% confidence intervals will be estimated for TP53 status as well as treatment hazard ratios (with Arm 1 as the reference arm) within TP53 subgroups. |
Up to 5 years
|
|
Incidence of adverse events (AEs) in treatment with bevacizumab when combined with carboplatin, paclitaxel, and pembrolizumab
Tijdsspanne: Up to 90 days after last dose of study treatment
|
The nature, frequency, and degree of toxicity will be tabulated at the system organ class and AE-specific term levels using Common Terminology Criteria for Adverse Events v 5.0. Each patient will be represented according to maximum grade observed for each term. Tabulations will show the number and percentage of patients by maximum grade, within the treatment group received, regardless of the randomized treatment assignment. No specific hypothesis test is pre-specified. |
Up to 90 days after last dose of study treatment
|
|
Objective response rate
Tijdsspanne: Within 12 months of initiating therapy
|
Will be defined as the binomial proportion of evaluable patients with a best overall response of complete response or partial response. Will be supported by their 2-sided, 95% Wilson-Score confidence intervals. The relative odds of response in each experimental group (vs the reference group) will be estimated using a multivariable logistic regression model specified with main effects for the treatment groups and stratified by the stratification factors reported at baseline. |
Within 12 months of initiating therapy
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
PFS
Tijdsspanne: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years
|
Will estimate the PFS treatment effect and the corresponding 95% confidence intervals by sex. |
From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years
|
|
PFS
Tijdsspanne: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years
|
Will estimate the PFS treatment effect and the corresponding 95% confidence intervals by race. |
From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years
|
|
PFS
Tijdsspanne: From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years
|
Will estimate the PFS treatment effect and the corresponding 95% confidence intervals by ethnicity. |
From study entry to time of progression or death, whichever occurs first, or date of last contact if neither progression nor death has occurred, assessed up to 5 years
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Amanda N Fader, NRG Oncology
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
- Urogenitale ziekten
- Genitale ziekten
- Urogenitale neoplasmata
- Neoplasmata per site
- Neoplasmata
- Vrouwelijke urogenitale ziekten
- Vrouwelijke urogenitale ziekten en zwangerschapscomplicaties
- Baarmoeder Ziekten
- Genitale ziekten, vrouw
- Genitale neoplasmata, vrouwelijk
- Baarmoeder Neoplasmata
- Endometriumneoplasmata
- Aminozuren, peptiden en eiwitten
- Eiwitten
- Zwavelverbindingen
- Organische chemicaliën
- Onderzoekstechnieken
- Klinische laboratoriumtechnieken
- Diagnostische technieken en procedures
- Diagnose
- Koolwaterstoffen
- Cycloparaffins
- Koolwaterstoffen, alicyclisch
- Koolwaterstoffen, cyclisch
- Terpenen
- Antilichamen, monoklonaal, gehumaniseerd
- Antilichamen, monoklonaal
- Antilichamen
- Immunoglobulinen
- Immunoproteïnen
- Bloedeiwitten
- Serum -globulines
- Globulines
- Anorganische chemicaliën
- Coördinatiecomplexen
- Taxoids
- Cyclodecanes
- Diterpenen
- Gezondheidszorg economie en organisaties
- Chemie -technieken, analytisch
- Spectrumanalyse
- Immunoglobuline -isotypes
- Sulfiden
- Anionen
- Ionen
- Elektrolyten
- Waterstofsulfide
- Economie
- Bevacizumab
- Carboplatine
- Paclitaxel
- Immunoglobuline G
- Exemplaarbehandeling
- pembrolizumab
- Magnetische resonantiespectroscopie
- Disulfides
- Belastingen
Andere studie-ID-nummers
- NCI-2025-06974
- U10CA180868 (Subsidie/contract van de Amerikaanse NIH)
- NCI-2025-06974 (Register-ID: CTRP (Clinical Trial Reporting Program))
- NRG-GY035 (Andere identificatie: CTEP)
- NRG-GY035 (Andere identificatie: NRG Oncology)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .